Wednesday, April 22

Healthcare

Biora Therapeutics granted extension to regain compliance with Nasdaq

08/29/20241 Min Read

Biora compliance extension granted Nasdaq regain Therapeutics

Previous ArticlePatterson Cos. stock falls 13% on fiscal Q1 earnings report

Next Article Avadel says court denies Jazz Pharma request on lumryz in narcolepsy (replace)